Key Takeaways
- Motion sickness results from a sensory conflict — your inner ear, eyes, and body position sensors send contradictory signals to the brain.
- The scopolamine transdermal patch is the most effective single agent for extended travel; apply it behind the ear at least 4 hours before departure, and it lasts 72 hours.[3]
- For short trips, over-the-counter options like meclizine and dimenhydrinate are practical first choices. The CDC recommends matching medication intensity to trip length and motion severity.[2]
- Non-drug strategies — horizon fixation, controlled breathing, acupressure at the P6 wrist point, and ginger — are effective and have no side effects.
- Children ages 2–12, women, and people with migraine history are at significantly higher risk.
- If dizziness occurs during head position changes (not during travel), consider BPPV — it requires a different evaluation and treatment entirely.
Every year, I see patients who have ruined a cruise, a road trip, or a transatlantic flight because they didn't know there was a reliable way to prevent motion sickness before it started. The biology is well understood. The treatment options are good. And yet the gap between available knowledge and what patients actually do about it remains wide.
Motion sickness affects a significant portion of the population. Roughly one-third of people are highly susceptible under ordinary travel conditions, and nearly everyone will experience it under sufficiently provocative circumstances — heavy sea swells, turbulent flights, or extended time in a virtual reality headset.[3] The good news is that both pharmacological and non-pharmacological strategies work, and the choice between them is largely a matter of matching the right tool to your specific situation.
This guide covers the science behind motion sickness, the full range of treatment and prevention options, who is most at risk, how different travel environments differ, and how telehealth prescribing for the scopolamine patch works. My goal is to give you everything you need to travel comfortably.
Why Motion Sickness Happens: The Sensory Conflict Theory
The leading explanation for motion sickness is the sensory conflict theory, first described systematically in the 1970s and still the most clinically useful framework today. The idea is straightforward: your brain receives motion information from three separate systems — the vestibular system (inner ear), the visual system (eyes), and proprioception (position sensors in your muscles, joints, and skin). When these systems disagree, the brain interprets the conflict as a threat and responds with nausea, sweating, pallor, and eventually vomiting.
Reading in a moving car is the clearest example. Your eyes are focused on a stationary page, signaling no movement. Your inner ear is detecting the car's acceleration, turns, and vibration. Your proprioceptive sensors feel your body moving with the vehicle. The visual signal says "still"; the other two say "moving." That mismatch is what triggers the sick feeling.
The Three Sensor Systems in Detail
The vestibular system sits in the inner ear and consists of the semicircular canals (which detect rotational acceleration) and the otolith organs — the utricle and saccule — which detect linear acceleration and gravity. These structures are exquisitely sensitive and detect even subtle changes in head movement and body position.
Visual input tells the brain where the environment is relative to your body. When you see movement in your peripheral vision, your brain normally interprets this as self-motion. In virtual reality, visual motion is displayed while your body stays still — a mismatch that reliably produces nausea in a large proportion of users.[6]
Proprioception is the body's internal position sense. Your muscles, tendons, and joint receptors constantly feed information to the brain about your body's orientation and movement. Passengers (rather than drivers) are more susceptible to motion sickness partly because drivers' proprioceptive signals match their vestibular input — they're anticipating and initiating the movements rather than passively experiencing them.
Why the Brain Responds With Nausea
One evolutionary theory holds that the sensory conflict pattern resembles what a person experiences after ingesting a neurotoxin — stumbling gait, perceptual distortion, loss of balance. Vomiting in that scenario would be protective. The motion sickness response may be an evolutionary misfiring of a protective emetic reflex, which would explain why anti-nausea medications developed for other purposes (anticholinergics and antihistamines) happen to be effective here.
Practically, this means all effective anti-motion-sickness drugs work centrally — they cross the blood-brain barrier and act on the vomiting center and vestibular pathways. Newer "non-drowsy" antihistamines like cetirizine and loratadine that are specifically designed to stay out of the brain are not effective for motion sickness, a fact that surprises many patients who reach for their allergy medications before a trip.[2]
Who Gets Motion Sickness: Risk Factors
Motion sickness susceptibility is not evenly distributed. Knowing where you fall on the susceptibility spectrum helps you decide how proactively to prepare.
Age
Children ages 2–12 are the highest-risk group, with peak susceptibility around ages 9–10.[6] Infants and toddlers under age 2 appear largely immune — their sensory systems may not yet generate the conflict response in the same way. Susceptibility generally decreases through adulthood, though it never disappears entirely.
Sex
Women are roughly 1.7 times more likely than men to vomit from motion exposure in real-world travel settings, based on survey data from sea voyagers.[6] Hormonal differences are thought to contribute — women tend to report worsened symptoms during certain phases of the menstrual cycle and during pregnancy. In virtual reality environments, women's higher susceptibility is partly attributed to differences in interpupillary distance and headset fit, on top of the underlying physiological factors.
Migraine History
People who experience migraines are significantly more prone to motion sickness, even between migraine episodes. This connection runs deep enough that some researchers view migraine and motion sickness as overlapping vestibular disorders.[6] Treating underlying migraine — both prophylactically and acutely — can reduce motion sickness severity in these patients. If you have frequent migraines and severe motion sickness, discussing both conditions with your physician at the same visit makes sense.
Genetics
Twin studies estimate that 55–70% of variation in motion sickness susceptibility is inherited, and researchers have identified 35 distinct genetic variants associated with increased risk.[6] If your parents were chronically seasick, your chances are higher. This is clinically relevant because it means some people genuinely need pharmacological protection in situations where others would be fine with behavioral strategies alone.
Vestibular Disorders
Patients with Meniere's disease, vestibular neuritis, or vestibular migraine are especially vulnerable to motion-provoked symptoms. Their vestibular systems are already sending abnormal signals at baseline, which amplifies the sensory conflict. These patients should always discuss their travel plans with a physician before selecting a prevention strategy.
Car Sickness, Sea Sickness, Air Sickness, and VR Sickness
The core mechanism is identical across all types, but the practical features differ enough to affect how you prevent and manage each one.
Car Sickness
Car sickness is most common in rear-seat passengers, particularly children. The key trigger is visual-vestibular mismatch — you feel the car's motion but can't see the road ahead to anticipate turns and stops. Sitting in the front seat, looking at the horizon through the windshield, and avoiding reading or screens resolves this conflict for most people. Drivers almost never get car sick because they initiate the vehicle's movements and their visual and vestibular inputs align. If behavioral strategies aren't enough, a short-acting oral antihistamine taken 30–60 minutes before departure is typically adequate for trips under 6 hours.
Sea Sickness
Sea sickness (mal de mer) involves sustained low-frequency rolling motion — typically 0.1–0.3 Hz — to which the inner ear is particularly sensitive. Symptoms can be severe and prolonged, especially in heavy swells. Scopolamine patches are particularly well-suited here because of their 72-hour continuous delivery. On a ship, choosing a cabin near the waterline amidships (the middle of the vessel) reduces the amplitude of motion. Spending time on deck looking at the horizon helps. Avoiding alcohol, which worsens nausea and impairs vestibular compensation, is also important.[2]
Air Sickness
Air sickness tends to occur during turbulence and steep banking maneuvers. Modern commercial aviation has made severe air sickness less common than in earlier eras of smaller aircraft, but it remains a real problem for some travelers. Seats over the wings experience the least motion; window seats allow horizon viewing. Passengers who are already anxious about flying may be more prone to symptoms because anxiety heightens the sensitivity of the nausea response.
Simulator Sickness and VR
Virtual reality sickness works through the same sensory mismatch as traditional motion sickness — visual motion without corresponding physical movement. Research shows that more than half of VR users experience symptoms within 15 minutes of play in some studies, with women affected at higher rates.[6] Frame rate, field of view, type of locomotion (artificial navigation is worse than room-scale movement), and headset fit all influence severity. Taking breaks every 15–20 minutes, starting with lower-intensity content, and ensuring proper headset fit are the most practical strategies. Anti-motion-sickness medications can help, but the most effective long-term solution for VR is habituation — gradually increasing exposure time over several sessions.
The CDC lists habituation (gradual desensitization) as the single most effective countermeasure for motion sickness — more effective than any medication and free of side effects.[2] Military pilots who experience motion sickness undergo structured desensitization programs with success rates above 85%. For everyday travelers, continuous exposure to the provoking stimulus generally resolves symptoms within 24–72 hours. The catch: if you go more than a week without re-exposure, you may lose that adaptation.
Non-Drug Strategies That Work
Before reaching for medication, it's worth knowing that several behavioral and complementary strategies have genuine evidence behind them. For patients with mild susceptibility, these may be all they need. For those with severe symptoms, combining them with medication improves outcomes.
Horizon Fixation
Looking at a stable, distant horizon is one of the most consistently effective behavioral strategies. It resolves the visual-vestibular conflict by giving your visual system a stable external reference that matches what your inner ear is sensing. On a ship, go up to the deck and look at the sea horizon. In a car, look at the far end of the road ahead. Studies have confirmed benefit in ships, ship simulators, buses, and cars.[2] Closing your eyes and reclining can work as a substitute when the horizon isn't visible.
Controlled Breathing
Slow, deliberate breathing — typically a 4-count inhale, 4-count hold, 4-count exhale — activates the parasympathetic nervous system and can attenuate the nausea response. This is the same mechanism behind its use in anxiety management. What I tell patients is to start controlled breathing at the first hint of discomfort, before nausea escalates. Once vomiting begins, the window for any non-pharmacological intervention has largely closed.
Seat Position and Head Restraint
In a car: sit in the front seat or behind the driver, facing forward. On a plane: choose a window seat over the wings. On a ship: stay amidships and low. Reducing head movements — holding your head against the headrest rather than letting it move freely — decreases the input of the motion signal to the semicircular canals and reduces symptoms in multiple transport environments.[3]
Acupressure: The P6 Point
The P6 (Neiguan) acupressure point is located on the inner wrist, approximately three finger-widths up from the wrist crease, between the tendons of the palmaris longus and flexor carpi radialis muscles. Stimulating this point — either manually or with an elastic wristband like Sea-Bands — has been studied for postoperative nausea, chemotherapy-related nausea, and pregnancy nausea. A group of evidence-based medicine reviewers concluded that P6 stimulation is an effective method for relieving postoperative nausea and may be useful for managing nausea in varied patient populations.[5] Evidence for motion sickness specifically is modest, but the approach is safe, inexpensive, and worth trying — especially for children or pregnant travelers who want to minimize medication exposure.
Ginger
Ginger has genuine antiemetic properties. It appears to work partly through direct effects on gastric motility and partly via central pathways. Ginger can be taken as capsules (standardized extract), ginger tea, ginger ale (real ginger content only), or ginger candies. The evidence is strongest for pregnancy-related nausea and chemotherapy nausea, but ginger is widely used and considered safe for motion sickness in adults and older children. It has no meaningful drug interactions and virtually no side effects at typical doses. For patients who want to avoid sedating medications for a day trip, ginger plus controlled breathing and good seat positioning is a reasonable first-line approach.
Avoid Alcohol and Avoid Screens
Alcohol worsens nausea and impairs vestibular compensation — this is especially relevant on cruise ships where drinking is common. Reading and screen use in moving vehicles exacerbate the visual-vestibular mismatch directly. Avoiding these while in transit is a simple, effective measure that patients often overlook until they've had a bad experience.
Medications for Motion Sickness
When behavioral strategies aren't enough — or when the travel stimulus is intense enough that medication is clearly warranted from the start — several well-studied options are available. The right choice depends on trip duration, intensity of expected motion, your medical history, and how much sedation you can tolerate.
Every anti-motion-sickness medication works far better when taken before exposure than after symptoms develop. Once nausea is established, gastric motility slows, oral absorption becomes unreliable, and the window for effective intervention narrows. Take medications 30–60 minutes (for most oral agents) or 4 hours (for the scopolamine patch) before your trip begins.[3]
Scopolamine Transdermal Patch (Transderm Scop)
Scopolamine is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the vestibular nuclei and the brain's vomiting center. It is currently the most effective single pharmacological agent for preventing motion sickness.[3] A Cochrane systematic review of 14 randomized controlled trials found that scopolamine was significantly more effective than placebo, with a risk ratio of 0.48 (meaning roughly half the rate of sickness symptoms) for preventing nausea — and was equivalent to or better than comparator antihistamines in most trials.[1]
The transdermal patch delivers 1 mg of scopolamine over 72 hours. Apply the patch to dry, hairless skin directly behind one ear at least 4 hours before travel begins — the onset is slow because the medication is absorbed through the skin. If you apply it the night before a morning departure, it will be at therapeutic levels when you board. For travel beyond 3 days, remove the original patch and apply a new one behind the opposite ear.[4]
In June 2025, the FDA required an updated warning for the Transderm Scop patch: scopolamine impairs the body's ability to regulate temperature, which can cause dangerous heat-related complications — including hospitalization and death — particularly in children 17 and under and adults over 60. Avoid strenuous activity in hot environments while wearing the patch. Keep children and older adults cool and well-hydrated. The FDA update does not change the patch's usefulness for most adult travelers but warrants specific caution for vulnerable groups.[7]
Side effects: The most common side effect is dry mouth, which occurs more frequently with scopolamine than with other agents. Drowsiness, blurred vision, and dizziness also occur but at rates similar to antihistamines in head-to-head comparisons. Always wash hands thoroughly after handling the patch — accidental finger-to-eye contact causes temporary pupil dilation and blurred vision.[4]
Scopolamine requires a prescription in the United States and is contraindicated in patients with narrow-angle glaucoma, urinary retention, and certain cardiac arrhythmias. A telehealth visit is an efficient way to obtain a prescription without an in-person appointment — see the section on telehealth prescribing below.
Antihistamines: Dimenhydrinate and Meclizine
Dimenhydrinate (Dramamine) is a first-generation antihistamine with both H1 receptor-blocking and some anticholinergic properties. It is available over the counter and is taken every 4–6 hours as needed. For most adults, the starting dose is 50–100 mg taken 30–60 minutes before travel. It's more effective than meclizine in head-to-head studies, though it requires more frequent dosing and causes more drowsiness.[8]
Meclizine (Bonine, Dramamine Less Drowsy) is a first-generation antihistamine with a longer duration of action — a single 25–50 mg dose lasts 8–24 hours in most people. It causes less drowsiness than dimenhydrinate, which makes it more practical for situations where alertness matters (such as driving the next leg of a road trip). It's approved for adults and children 12 and older.[2]
Promethazine
Promethazine (Phenergan) is a first-generation antihistamine with strong anticholinergic properties and is the most potent antihistamine option for motion sickness. It's available by prescription in oral, rectal, and intramuscular preparations and has been studied in space motion sickness, where intramuscular injections are used. Its limitations are significant sedation and potential impairment of cognitive performance. Combining promethazine with caffeine can partially offset the sedation.[3] Promethazine is reserved for severe cases or when oral absorption is compromised — not a first choice for routine travel.
What About Ondansetron (Zofran)?
Ondansetron is a 5-HT3 (serotonin) receptor antagonist widely used for chemotherapy-related and post-operative nausea. Patients sometimes ask about it because it's effective for those indications and causes less drowsiness. Evidence for motion sickness specifically is limited and generally not supportive — StatPearls notes that serotonin receptor antagonists inhibit gastric rhythm disruption but do not reliably prevent motion sickness symptoms.[3] Ondansetron is not a recommended first-line agent for motion sickness. That said, some patients with complex histories who cannot use anticholinergics or antihistamines may be given a trial — this is a conversation to have with your physician.
Medication Comparison Table
| Medication | Class | Route | Onset | Duration | Rx Required? | Key Side Effects | Best For |
|---|---|---|---|---|---|---|---|
| Scopolamine patch (Transderm Scop) | Anticholinergic | Transdermal | 4–8 hours | 72 hours | Yes | Dry mouth, drowsiness, blurred vision (eye contact) | Long-distance travel, cruises, multi-day trips |
| Dimenhydrinate (Dramamine) | Antihistamine (H1) | Oral | 30–60 min | 4–6 hours | No (OTC) | Significant drowsiness, dry mouth | Short to moderate trips; children over 2 |
| Meclizine (Bonine, Dramamine Less Drowsy) | Antihistamine (H1) | Oral | 1–2 hours | 8–24 hours | No (OTC) | Moderate drowsiness (less than dimenhydrinate) | Day-long travel; adults and teens 12+ |
| Promethazine (Phenergan) | Antihistamine / Anticholinergic | Oral, IM, rectal | 2 hours (oral) | Up to 15 hours | Yes | Heavy sedation, cognitive impairment | Severe cases; non-oral routes when vomiting present |
| Ondansetron (Zofran) | 5-HT3 antagonist | Oral, ODT, IV | 30–60 min | 4–8 hours | Yes | Headache, constipation, QT prolongation (rare) | Limited evidence for motion sickness; off-label use only |
Sources: CDC Yellow Book (2025); StatPearls: Motion Sickness
Matching Medication to Trip Length and Stimulus Intensity
The CDC Yellow Book provides a practical framework for selecting medications based on both trip duration and how intense the motion stimulus is likely to be.[2] In my practice, this is the framework I walk patients through when they're planning travel:
| Trip Duration | Motion Intensity | Recommended Approach |
|---|---|---|
| Short (≤6 hours) | Mild to moderate | Meclizine or dimenhydrinate; behavioral strategies first |
| Short (≤6 hours) | Intense (rough seas, turbulence) | Promethazine |
| Long (>6 hours) | Mild | Meclizine or dimenhydrinate |
| Long (>6 hours) | Moderate to intense | Scopolamine transdermal patch — preferred |
When It Might Not Be Motion Sickness: BPPV and Other Vestibular Causes
Not every episode of dizziness or nausea in the context of movement is motion sickness. One condition that frequently gets confused with motion sickness is benign paroxysmal positional vertigo (BPPV), and the distinction matters because BPPV responds to a completely different treatment.
What Is BPPV?
BPPV is the most common vestibular disorder. It occurs when calcium carbonate crystals (otoconia) that normally sit in the utricle of the inner ear become dislodged and migrate into one of the semicircular canals. When the head moves into certain positions, these displaced crystals create abnormal fluid movement in the canal, causing intense but brief spinning sensations.[9]
How to Tell the Difference
| Feature | Motion Sickness | BPPV |
|---|---|---|
| Trigger | Moving vehicle, boat, plane, VR | Specific head positions (rolling over in bed, looking up, bending forward) |
| Vertigo quality | Nausea-dominant, general malaise | Intense spinning sensation, usually <1 minute |
| Timing | Gradual onset during travel | Sudden onset with positional change; resolves quickly |
| Hearing or neurological changes | None | None in BPPV; if present, warrants urgent evaluation for other cause |
| Treatment | Anticholinergics, antihistamines, behavioral strategies | Epley maneuver (canal repositioning) — highly effective |
If your dizziness occurs predictably when rolling over in bed, tilting your head back, or leaning forward — rather than during travel — you should be evaluated by a physician for BPPV. The Epley maneuver, a specific series of head positioning movements performed in a clinical setting, resolves BPPV in the majority of cases after one or two treatments. Anti-motion-sickness medications will not fix it.
Dizziness is rarely an emergency, but certain features should prompt immediate care: sudden severe vertigo with hearing loss (possible sudden hearing loss), dizziness with double vision, slurred speech, facial weakness, or limb coordination problems (possible stroke), or new continuous dizziness that is not triggered by position or motion. If you have any of these "red flag" symptoms, seek emergency evaluation rather than treating yourself for motion sickness.
Getting a Scopolamine Prescription Through Telehealth
The scopolamine transdermal patch is a prescription medication in the United States, but it's one of the most practical conditions to address via telehealth. There's no physical exam required. The clinical questions are straightforward. And the need is typically time-sensitive — you have a cruise in two weeks, a transatlantic flight coming up, or a child who has suffered through every family road trip for years.
What a Telehealth Visit for Motion Sickness Covers
During a telehealth visit, the physician reviews your travel plans, the type and expected duration of motion exposure, your complete medication list (anticholinergic effects can compound if you're already taking medications with similar properties), and relevant medical history — specifically glaucoma, urinary retention, cardiac rhythm conditions, and age factors that affect the heat warning issued by the FDA in 2025.
For most healthy adults planning a cruise or extended travel, the visit takes 10–15 minutes and results in a prescription sent directly to your pharmacy. Generic scopolamine patches are widely available.
Planning Ahead
The patch needs to be applied 4 hours before departure, so you need the prescription in hand before your travel day. Reach out at least a week in advance to allow time for the telehealth visit and pharmacy fulfillment. If you're unsure whether the patch is right for you versus an over-the-counter option, that's exactly the kind of question a brief telehealth consultation can answer quickly.
Contact TeleDirectMD at 678-956-1855 or contact@teledirectmd.com to schedule a visit.
Motion Sickness in Children
Children ages 2–12 are disproportionately affected. As the parent, watching your child get sick in the car or on a boat is genuinely distressing — and often preventable with the right strategy applied before departure.
Behavioral strategies work in children just as in adults: front-seat or forward-facing window positions, horizon viewing, and avoiding screens and reading during travel. These should be the first line of action, particularly for mild cases.
For pharmacological prevention, dimenhydrinate is the most commonly used agent in children over age 2, dosed by weight. Meclizine is approved for ages 12 and older. Scopolamine patches are not approved for children, and the 2025 FDA warning specifically called out children 17 and under as a group at increased risk for heat-related complications from scopolamine's anticholinergic effects.[7]
Always consult a physician before using any medication in a child under 12 for motion sickness. Dose calculation errors in children can have serious consequences, and the clinical picture in young children can differ from adults in ways that warrant professional guidance.
Frequently Asked Questions
For short trips (under 6 hours), meclizine or dimenhydrinate (Dramamine) taken 30–60 minutes before travel are practical first choices available without a prescription. For longer travel — especially cruises or multi-day trips — the scopolamine transdermal patch (Transderm Scop) is generally more effective. Applied behind the ear at least 4 hours before departure, it delivers continuous medication for up to 72 hours and causes less drowsiness than most antihistamines. Promethazine is the strongest antihistamine option and is reserved for severe cases due to its sedating effects. The right choice depends on trip length, your medical history, and side-effect tolerance — a quick telehealth visit can help you decide.
Scopolamine is an anticholinergic agent that blocks acetylcholine receptors in the brain's vomiting center and vestibular pathways, reducing the signals that trigger nausea. The patch is applied to the hairless skin directly behind one ear at least 4 hours before you need it to be effective. It delivers 1 mg of scopolamine over 72 hours. If travel extends beyond 3 days, remove the original patch and apply a new one behind the opposite ear. Wash your hands thoroughly after handling the patch — accidental eye contact can cause temporary pupil dilation and blurred vision. Scopolamine requires a prescription in the United States.
Children ages 2–12 are among the most susceptible age group for motion sickness. Dimenhydrinate is available for children over age 2 in weight-based doses. Meclizine is approved for ages 12 and older. The scopolamine patch is not approved for children, and the FDA has specifically warned about the risk of heat-related complications in children 17 and under. Always consult a physician before giving any motion sickness medication to a child, particularly younger children, as dosing errors are a real safety concern.
Yes — behavioral strategies are considered among the most effective countermeasures available, and they come without the side effects of medications. Fixing your gaze on the horizon, sitting in forward-facing seats, minimizing head movements, and controlled breathing all have evidence behind them. Acupressure wristbands targeting the P6 (Neiguan) point on the inner wrist have been studied and show modest benefit for nausea prevention without any safety concerns. Ginger (in capsule, tea, or candy form) has genuine antiemetic properties and is safe for most people. These strategies work best when combined — and they're especially useful if you want to avoid medication side effects or if you're the one driving.
All three arise from the same underlying mechanism — a mismatch between what your eyes, inner ear, and body sense receptors are reporting. The specific triggers differ. Car sickness is most common in rear passengers who can't see the road ahead; sitting in the front seat or looking out the windshield resolves the visual-vestibular conflict. Sea sickness involves low-frequency rolling motion, which the inner ear is particularly sensitive to; a calm cabin in the ship's middle section reduces movement. Air sickness tends to occur during turbulence or steep banking. All three respond to the same medications, but the duration and intensity differ, which guides medication selection.
Benign paroxysmal positional vertigo (BPPV) is an inner ear disorder in which displaced calcium crystals in the semicircular canals cause brief, intense spinning sensations triggered by specific head movements — typically rolling over in bed, looking up, or bending forward. Unlike motion sickness, BPPV is not triggered by travel or movement of your environment. The vertigo episodes in BPPV typically last less than a minute and are linked to specific positional changes. If your dizziness occurs in those circumstances rather than during travel, you should be evaluated for BPPV, which is treated with a repositioning maneuver (the Epley maneuver) rather than anti-motion-sickness medications.
Yes. Simulator sickness — including VR-induced motion sickness — works through the same sensory conflict mechanism as traditional motion sickness. Your eyes perceive movement while your body remains stationary, creating a mismatch. Studies show that more than half of VR users experience symptoms within 15 minutes of play in some conditions, with women affected at a higher rate. Contributing factors include low frame rates, high-motion content, and ill-fitting headsets. Strategies to reduce VR sickness include taking frequent breaks, starting with less intense content, choosing room-scale experiences over artificial locomotion, and ensuring headset fit and interpupillary distance settings are correct.
The peak age range for motion sickness susceptibility is children ages 2–12, particularly around ages 9–10. Adults with a history of migraine headaches are significantly more prone to motion sickness. Women are roughly 1.7 times more likely than men to vomit from motion exposure at sea. People with vestibular disorders, Meniere's disease, or a strong family history of motion sickness are also at elevated risk. Interestingly, very young infants appear largely immune, and susceptibility typically decreases again after young adulthood.
Ondansetron (Zofran) is a powerful antiemetic widely used for chemotherapy-related nausea and post-operative nausea, but evidence for motion sickness specifically is limited. Studies indicate that serotonin (5-HT3) receptor antagonists like ondansetron do not reliably prevent motion sickness symptoms. It is not a recommended first-line agent for this indication. In practice, it may be considered in patients who cannot tolerate anticholinergics or antihistamines, but scopolamine and the antihistamines remain the better-supported options for motion sickness prevention.
Yes. The scopolamine transdermal patch is a prescription medication, but it's well-suited for telehealth prescribing. A physician can review your travel plans, medical history, current medications, and any contraindications during a brief visit and send a prescription to your pharmacy. Most pharmacies carry the generic version of the patch. Telehealth visits through TeleDirectMD can be arranged quickly — contact us at 678-956-1855 or contact@teledirectmd.com.
References & Sources
- Spinks A, Wasiak J. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database of Systematic Reviews. 2011. https://pmc.ncbi.nlm.nih.gov/articles/PMC7138049/
- Centers for Disease Control and Prevention. Motion Sickness. CDC Yellow Book 2024: Health Information for International Travel. Updated April 2025. https://www.cdc.gov/yellow-book/hcp/travel-air-sea/motion-sickness.html
- Nguyen-Huynh AT. Motion Sickness. In: StatPearls. StatPearls Publishing; updated July 2023. https://www.ncbi.nlm.nih.gov/books/NBK539706/
- MedlinePlus. Scopolamine Transdermal Patch. U.S. National Library of Medicine. Updated 2025. https://medlineplus.gov/druginfo/meds/a682509.html
- Tara F, Poorjavad M, Aghaei MA, et al. Acupressure and Ginger to Relieve Nausea and Vomiting in Women. Iranian Red Crescent Medical Journal. 2014. https://pmc.ncbi.nlm.nih.gov/articles/PMC3929824/
- Nooij SAE, et al. Predicting Individual Susceptibility to Visually Induced Motion Sickness. Frontiers in Virtual Reality. 2021. https://www.frontiersin.org/journals/virtual-reality/articles/10.3389/frvir.2021.576871/full
- U.S. Food & Drug Administration. Transderm Scop (Scopolamine Transdermal System): FDA Drug Safety Communication — Heat-Related Complications. June 2025. https://www.fda.gov/safety/medical-product-safety-information/transderm-scop-scopolamine-transdermal-system-drug-safety-communication-fda-adds-warning-about
- UC Davis Health. Motion Sickness: How You Can Prevent Symptoms and Enjoy Travel. May 2024. https://health.ucdavis.edu/blog/cultivating-health/motion-sickness-how-you-can-prevent-symptoms-and-enjoy-travel/2024/05
- Mayo Clinic. Benign Paroxysmal Positional Vertigo (BPPV) — Symptoms and Causes. Updated December 2025. https://www.mayoclinic.org/diseases-conditions/vertigo/symptoms-causes/syc-20370055